Deborah Stephens

Assistant Professor

Huntsman Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Deborah Stephens is an Assistant Professor at the Huntsman Cancer Institute in the United States. Her research focuses on chronic lymphocytic leukemia, with recent articles exploring topics such as the implications of karyotypic evaluation, outcomes of CART treatments, and the effectiveness of various therapies. She is actively involved in developing clinical practice recommendations and consensus guidelines for the treatment of lymphoma and related conditions.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (14)

Catherine Lai

UNITED STATES

View details

Peter Hillmen

UNITED KINGDOM

View details

Geoffrey Shouse

Assistant Clinical Professor

City Of Hope National Medical Center

UNITED STATES

View details

Reem Karmali

Assistant Professor

Northwestern University

UNITED STATES

View details

Natalie Grover

Assistant Professor

University of North Carolina at Chapel Hill School of Medicine

UNITED STATES

View details

Christopher Jensen

University of North Carolina

UNITED STATES

View details

Ambuj Kumar

University of South Florida

UNITED STATES

View details

Ayushi Chauhan

Assistant Professor, Lymphoid Malignancies and Bone Marrow Transplantation

Augusta University

UNITED STATES

View details

Ken Ogasawara

Bristol-Myers Squibb

UNITED STATES

View details

schuh Anna

University of Oxford

UNITED KINGDOM

View details

Jacqueline Claudia Barrientos

Professor

Northwell Health

UNITED STATES

View details

Ajay Gopal

University of Washington

UNITED STATES

View details

Tanya Siddiqi

Associate Professor

City Of Hope National Medical Center

UNITED STATES

View details

Marc Hoffmann

Assistant Professor

University of Kansas Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Deborah Stephens

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART

Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective

Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL

Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Long-read single-cell RNA sequencing enables the study of cancer subclone-specific genotypes and phenotypes in chronic lymphocytic leukemia.

Double hit &amp; double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data

Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open-label study (ACE-LY-003).

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL

Second-Generation Bruton's Tyrosine Kinase Inhibitors: Simply the Best Treatments for Chronic Lymphocytic Leukemia?

Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies

Acalabrutinib in treatment-naive chronic lymphocytic leukemia

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results.

Reply to: Interim PET assessment of advanced Hodgkin Lymphoma: is it sufficient?

Collaborators (14)

Catherine Lai

Peter Hillmen

Geoffrey Shouse

Reem Karmali

Natalie Grover

Christopher Jensen

Ambuj Kumar

Ayushi Chauhan

Ken Ogasawara

schuh Anna

Jacqueline Claudia Barrientos

Ajay Gopal

Tanya Siddiqi

Marc Hoffmann

Make your next move.

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.